A class action lawsuit has been filed against Concorde International Group alleging securities fraud related to its April 2025 IPO. The complaint claims that Concorde's IPO had a very low public float (under 3%) and concentrated insider voting control, which allowed price manipulation that inflated shares from $4 to over $31 before crashing to around $2. The lawsuit argues that the company failed to disclose these risks and ongoing regulatory scrutiny of similar micro-cap structures, misleading investors. The court deadline to apply as lead plaintiff is May 18, 2026, as investors seek to recover losses from the significant share price collapse.
Ipsen has introduced corabotase, the first molecule in a new class of recombinant neuroinhibitors, designed to treat moderate to severe upper facial lines such as glabellar lines. Phase II trial data presented at the SCALE Symposium showed corabotase...
Ipsen has introduced corabotase, the first molecule in a new class of recombinant neuro-inhibitors, at the SCALE symposium. Phase II trial data show corabotase's safety and efficacy in treating moderate to severe facial wrinkles, including glabellar ...
Ethereum's exchange reserves have fallen to about 14.9 million ETH, indicating less available supply for selling. Meanwhile, traders are increasing their exposure to ETH, as shown by rising Open Interest, which has recovered to $15.7 billion after a ...
On May 14, 2026, Michelin executed a share buyback program, repurchasing 214,275 of its ordinary shares at an average price of €30.54 per share. The shares were bought over-the-counter through multiple platforms and are intended for cancellation, whi...
ITV Studios expects its profit margins to be at the lower end of its 13%-15% target this year, despite a 4% revenue increase driven by global streaming deals. The division's revenue and profit are expected to be stronger in the second half due to lar...
